Background of the International Workshop

The scope of veterinary pharmacovigilance as defined in Article 73 of Directive 2001/82/EC as amended covers not only suspected adverse reactions in animals to veterinary medicinal products used under normal conditions of use, but also other aspects of post-authorization surveillance as potential environmental problems. However, there is a discrepancy between the general obligation to report on potential environmental problems and the question how to fulfill this obligation. The workshop aims to review the current state of Eco-pharmacovigilance of veterinary medi-cinal products and to discuss opportunities to enhance the system.

Attention! Registration ist over